CO2017005383A2 - Composiciones inhibidoras - Google Patents

Composiciones inhibidoras

Info

Publication number
CO2017005383A2
CO2017005383A2 CONC2017/0005383A CO2017005383A CO2017005383A2 CO 2017005383 A2 CO2017005383 A2 CO 2017005383A2 CO 2017005383 A CO2017005383 A CO 2017005383A CO 2017005383 A2 CO2017005383 A2 CO 2017005383A2
Authority
CO
Colombia
Prior art keywords
subject
composition
absorption
inhibitory compositions
compositions
Prior art date
Application number
CONC2017/0005383A
Other languages
English (en)
Inventor
Pee Win Chong
Bee Kwan Tan
Original Assignee
Inqpharm Group Sdn Bhd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inqpharm Group Sdn Bhd filed Critical Inqpharm Group Sdn Bhd
Publication of CO2017005383A2 publication Critical patent/CO2017005383A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03Organic compounds
    • A23L29/035Organic compounds containing oxygen as heteroatom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332Promoters of weight control and weight loss
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

RESUMEN La presente invención se refiere a una composición que comprende una pentosa y uno o más compuestos polifenólicos, y al uso de dichas composiciones para controlar o reducir la absorción de glucosa y/o lípidos en un sujeto y/o la absorción de calorías a partir de, carbohidrato y/o grasa proteína de la dieta en un sujeto. La composición puede usarse para inhibir una o más enzimas seleccionadas de α-glucosidasa, α-amilasa, lipasa y proteasa. La composición puede usarse para tratar o prevenir la obesidad y/o síndrome metabólico y/o hiperglucemia y/o hiperlipidemia en un sujeto.
CONC2017/0005383A 2014-11-27 2017-05-26 Composiciones inhibidoras CO2017005383A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI2014703552 2014-11-27
PCT/MY2015/000098 WO2016085321A2 (en) 2014-11-27 2015-11-26 Inhibitory compositions

Publications (1)

Publication Number Publication Date
CO2017005383A2 true CO2017005383A2 (es) 2017-09-20

Family

ID=55135496

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2017/0005383A CO2017005383A2 (es) 2014-11-27 2017-05-26 Composiciones inhibidoras

Country Status (14)

Country Link
US (1) US20180200274A1 (es)
EP (1) EP3223841A2 (es)
JP (1) JP2017538693A (es)
KR (1) KR20170089902A (es)
CN (1) CN106999595A (es)
AU (1) AU2015354844B2 (es)
BR (1) BR112017011122A2 (es)
CA (1) CA2967260A1 (es)
CO (1) CO2017005383A2 (es)
EA (1) EA038456B1 (es)
GE (1) GEP20217236B (es)
MX (1) MX2017006827A (es)
UA (1) UA124965C2 (es)
WO (1) WO2016085321A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018271887A1 (en) * 2017-05-25 2019-11-07 Sami Labs Limited Enzyme composition for management of metabolic health
JP2019094313A (ja) * 2017-11-28 2019-06-20 ビオフェルミン製薬株式会社 腹部膨満感改善用組成物及び腹部膨満感改善作用を有する物質又は組成物をスクリーニングする方法
BE1025428B1 (nl) * 2018-01-23 2019-02-14 Omega Pharma Innovation & Development Nv Voedingssupplement en gebruiken daarvan
ES2724728A1 (es) * 2018-03-08 2019-09-13 Bodega Matarromera S L Composición para la regulación del metabolismo de la glucosa

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012057A1 (en) * 1992-11-25 1994-06-09 Fujisawa Pharmaceutical Co., Ltd. Diet sweetener
FR2773150B1 (fr) * 1997-12-30 2000-03-31 Ferco Procede d'obtention d'un tanin de raisin, tanin obtenu et utilisations
FR2790645B1 (fr) * 1999-03-12 2001-06-08 Arkopharma Laboratoires Complement alimentaire et procede de traitement cosmetique a base d' un extrait de raisin riche en polyphenols
FR2836337B1 (fr) * 2002-02-28 2004-11-19 Bio Serae Laboratoires Utilisation des polymeres procyanidoliques a titre d'agents inhibuteurs des alpha-amylases et application dans des compositions a visees dietetiques
US7037535B2 (en) * 2002-11-19 2006-05-02 Kimberly-Clark Worldwide, Inc. Method and composition for neutralizing house dust mite feces
US20040115285A1 (en) * 2002-12-13 2004-06-17 Peter Rohdewald Method of normalizing glucose levels in blood of patients with diabetes mellitus by oral administration of proanthocyanidins containing plant extracts
KR101234392B1 (ko) 2004-07-05 2013-02-18 산토리 홀딩스 가부시키가이샤 리파아제 저해제
JP2008094754A (ja) * 2006-10-11 2008-04-24 En Otsuka Pharmaceutical Co Ltd 糖尿病または血糖コントロール用栄養組成物
WO2008093670A1 (ja) * 2007-02-01 2008-08-07 Tk Bio-Research Laboratory Co., Ltd. ブドウ果皮・種子乳酸菌発酵物、並びにそれを利用した医薬及び食品
JP2010059105A (ja) * 2008-09-04 2010-03-18 Unitika Ltd 炎症性腸疾患の予防又は治療剤
CN101822754B (zh) * 2010-05-28 2012-05-23 江苏大学 葡萄籽提取物的双频超声辅助提取方法及作为脂肪酶抑制剂的应用
CN102630753A (zh) * 2012-03-05 2012-08-15 苏州先阔生物科技有限公司 具有降糖降脂作用的豆奶
CN102614203A (zh) * 2012-03-05 2012-08-01 苏州先阔生物科技有限公司 具有α-葡萄糖苷酶抑制作用的低聚木糖组合物及其应用
CN102613456B (zh) * 2012-03-05 2014-07-23 陈功 具有脂肪酶活性抑制作用低聚木糖组合物及其应用
CN102652525A (zh) * 2012-05-07 2012-09-05 山东协力生物科技有限公司 一种l-阿拉伯糖功能硬糖及其制作方法
CN103610053B (zh) * 2013-11-27 2015-07-15 河西学院 一种高纯度葡萄籽提取物片剂及其制备方法

Also Published As

Publication number Publication date
MX2017006827A (es) 2018-01-30
JP2017538693A (ja) 2017-12-28
AU2015354844B2 (en) 2021-03-04
EA201791173A1 (ru) 2018-01-31
UA124965C2 (uk) 2021-12-22
CA2967260A1 (en) 2016-06-02
EP3223841A2 (en) 2017-10-04
CN106999595A (zh) 2017-08-01
BR112017011122A2 (pt) 2018-01-23
EA038456B1 (ru) 2021-08-31
WO2016085321A3 (en) 2016-08-04
AU2015354844A1 (en) 2017-05-04
GEP20217236B (en) 2021-03-25
WO2016085321A2 (en) 2016-06-02
KR20170089902A (ko) 2017-08-04
US20180200274A1 (en) 2018-07-19

Similar Documents

Publication Publication Date Title
CO2017005383A2 (es) Composiciones inhibidoras
EA201501032A1 (ru) Фармацевтическая композиция, способы лечения и ее применения
PH12015502275A1 (en) Therapuetic uses of empagliflozin
CL2013001433A1 (es) Composicion que comprende al menos una n-acetil lactosamina, al menos un oligosacarido sialilado al menos un oligosacarido fucosilado; y su uso en la prevencion de infecciones respiratorias agudas y/o para aliviar los sintomas de dichas infecciones.
BR112015023484A2 (pt) composição de carboidrato, produto e processso para preparar uma composição de carboidrato
EA201400119A1 (ru) Фармацевтическая композиция, способы лечения и их применение
ECSP13012661A (es) Composición farmacéutica, métodos de tratamiento y usos de la misma.
BR112017004744A2 (pt) corpo vegetal enxertado e método para a produção do mesmo
MX2020010004A (es) Composicion farmaceutica que comprende empagliflozina, metodos para tratamiento y sus usos.
WO2015034812A3 (en) A new ketogenic diet and its use in treating the critically ill
BR112018003745A2 (pt) composições que compreendem um composto de urolitina
BR112012019351A2 (pt) composição de combinação, que inclui como ingredientes ativos l-carnitina ou propionil l-carnitina, para a prevenção ou tratamento de insuficiência venosa crônica.
BR112018003780A2 (pt) composições que compreendem um composto de urolitina
BR112016007487A2 (pt) composições compreendendo citrulina e leucina e seu uso no tratamento de diabetes e de síndrome meta-bólica
BR112019011802A2 (pt) composições nutricionais contendo butirato e/ou lactoferrina e usos das mesmas
BR112012033739A8 (pt) Isomaltulose para uso no aumento do desempenho mental
ZA201702977B (en) Nutritional composition with low content of medium-chain fatty acids in specific proportions, and its uses.
BR112017010945A2 (pt) uso de proteína vegetal hidrolisada enzimaticamente na preparação de bebidas fermentadas
BR112012003643B8 (pt) composição alimentícia antibacteriana, usos de uma composição e kit
NZ702645A (en) A method of improving liver function
BR112018074747A2 (pt) utilizações de um agente imobilizado, composição comestível e utilização da composição
BR112017004563A2 (pt) compostos de dipeptidil cetoamida e seu uso para o tratamento e / ou prevenção do acúmulo de gordura
BR112018010616A2 (pt) compostos inibidores seletivos de mmp-12
BR112018010489A8 (pt) tratamento para administração via oral, softgel, comprimido ou cápsula, método de redução dos efeitos psicoativos do thc em humanos, e solução ou tintura de lipossomos
BR112017009743A2 (pt) produto de bebida com tartarato de sódio e potássio